Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Dacoplice 45mg Tablet
Manufacturer/Marketed By : PFIZER LTD
$648.89 $508.37
Dacoplice 45mg tablet contains the active substance Dacomitinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. It is used as a first-line treatment in adults...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
DACOMITINIB
Active Pharmaceutical Ingredient
Dacoplice 45mg Tablet
648.89$
508.37$
Dacoplice 45mg tablet contains the active substance Dacomitinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. It is used as a first-line treatment in adults with a type of lung cancer called non-small cell lung cancer which has spread to other parts of the body, and if a test has shown that your cancer has certain changes in a gene called EGFR (epidermal growth factor receptor). Do not take Dacoplice 45mg tablet if you are allergic to dacomitinib or any other ingredients of this medicine. Before initiating the treatment, inform your physician if you have any other lung problems because some lung problems may get worse during treatment with this medicine. Report to your doctor immediately if you develop diarrhoea, skin rash, or symptoms of jaundice, including yellowing of your skin and eyes, dark or brown urine, and light-coloured bowel movements. Dacoplice 45mg Tablet is not indicated in children or adolescents under the age of 18 years. Inform your physician if you have any heart disease, liver disorder, or kidney problems before initiating the treatment. The most common side effects are skin rash, changes in nails, inflamed sore mouth, decreased appetite, dry skin, decreased weight, hair loss, cough, and severe itching of the skin. This medicine is not recommended for pregnant and breastfeeding women.
Active Pharmaceutical Ingredient
Uses
• Metastatic non-small cell lung cancer with positive EGFR
Benefits
Dacomitinib is a protein-tyrosine kinase inhibitor that blocks a specific abnormal protein created by a chromosomal abnormality that signals cancer cells to multiply. It inhibits the multiplication and induces cell death in abnormal cancer cells.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Severe itchy skin
• Diarrhea
• Respiratory illness
Common Side Effects
• Hair fall
• Inflammation in the nails
• Itchy skin
• Dry skin
• Decreased weight
• Decreased appetite
• Inflamed and sore mouth
• cough
How To Use
Your doctor will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Take the tablets as prescribed by your doctor. Do not break, crush, or chew the tablets. Swallow the tablet whole with a glass of water. Take this medicine with a meal to avoid stomach problems. Take the tablet at about the same time each day.
Safety Advice
• Breast Feeding: Breastfeeding is not recommended in patients taking Dacoplice 45mg Tablet because the medicine passes into the breast milk in small amounts and may harm your baby.
• Alcohol: It is not known whether it is safe to consume alcohol with Dacoplice 45mg Tablet. Please consult your doctor.
• Liver: Dacoplice 45mg Tablet is safe when administered in patients with liver diseases. No dose adjustments are necessary for mild, moderate or severe liver failure. Inform your physician if you have liver problems before initiating the therapy.
• Lungs: It is unknown whether Dacoplice 45mg Tablet can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Driving or operating heavy machinery is unsafe after taking Dacoplice 45mg Tablet because you may feel dizzy, drowsy, or have eye irritation.
• Pregnancy: Dacoplice 45mg Tablet is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. An effective birth control method is necessary during the treatment and for 17 days after your last dose.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.